Medicare Enrolled
Dr. Marek Stawiski, MD
Dermatopathology Physician · Grand Rapids, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stawiski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stawiski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stawiski
Dr. Marek Stawiski is a dermatopathology physician in Grand Rapids, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Stawiski performed 3,189 Medicare services across 2,151 unique beneficiaries.
Between the years covered by Open Payments, Dr. Stawiski received a total of $22,892 from 44 pharmaceutical and/or device companies across 1198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stawiski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 43% volume in MI
$22,892 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,189
Medicare services
Top 43% in MI for dermatopathology physician
2,151
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~159 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
774 | $4 | $25 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
372 | $36 | $100 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
342 | $27 | $140 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $35 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
311 | $54 | $100 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
192 | $63 | $160 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
161 | $78 | $135 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
121 | $42 | $90 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
113 | $37 | $90 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
83 | $63 | $140 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
76 | $108 | $300 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
68 | $68 | $165 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $8 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $109 | $210 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
23 | $84 | $255 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
23 | $125 | $321 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
21 | $46 | $150 |
| Destruction of small cancerous skin growth on face or mouth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth. |
21 | $70 | $215 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
20 | $45 | $116 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
20 | $55 | $160 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
20 | $117 | $250 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
16 | $80 | $195 |
| Destruction of cancer skin growth on trunk, arms, or legs, 0.5 cm or less This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that is 0.5 centimeters or smaller in size. |
14 | $56 | $171 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
11 | $86 | $190 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,892
Total received (2018-2024)
Avg $3,270/year across 7 years
Top 7% in MI for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,198
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,467 (93.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,060 (4.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$365 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,121
2023
$3,473
2022
$3,430
2021
$3,516
2020
$2,582
2019
$3,492
2018
$2,278
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$605
GENZYME CORPORATION
$575
ABBVIE INC.
$557
E.R. Squibb & Sons, L.L.C.
$482
PFIZER INC.
$405
Novartis Pharmaceuticals Corporation
$317
SUN PHARMACEUTICAL INDUSTRIES INC.
$246
UCB, Inc.
$190
Boehringer Ingelheim Pharmaceuticals, Inc.
$144
Amgen Inc.
$110
Fresenius Kabi USA, LLC
$97
LEO Pharma Inc.
$90
Ortho Dermatologics, a division of Bausch Health US, LLC
$78
Regeneron Healthcare Solutions, Inc.
$68
Lilly USA, LLC
$63
Galderma Laboratories, L.P.
$38
Incyte Corporation
$22
Arcutis Biotherapeutics, Inc.
$19
Sandoz Inc.
$14
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,162
Janssen Biotech, Inc.
$2,306
AbbVie Inc.
$1,984
Amgen Inc.
$1,517
GENZYME CORPORATION
$1,408
PFIZER INC.
$1,339
E.R. Squibb & Sons, L.L.C.
$1,262
ABBVIE INC.
$1,173
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,058
UCB, Inc.
$940
Sun Pharmaceutical Industries Inc.
$920
Regeneron Healthcare Solutions, Inc.
$876
Celgene Corporation
$733
Lilly USA, LLC
$694
AbbVie, Inc.
$638
Boehringer Ingelheim Pharmaceuticals, Inc.
$384
LEO Pharma Inc.
$372
Incyte Corporation
$361
SUN PHARMACEUTICAL INDUSTRIES INC.
$265
Janssen Scientific Affairs, LLC
$244
Galderma Laboratories, L.P.
$141
Fresenius Kabi USA, LLC
$139
Almirall LLC
$110
Dermavant Sciences, Inc.
$98
Kyowa Kirin, Inc.
$75
Helsinn Therapeutics (U.S.), Inc.
$71
SANOFI-AVENTIS U.S. LLC
$65
VYNE Pharmaceuticals Inc.
$57
Arcutis Biotherapeutics, Inc.
$52
Biofrontera Inc.
$49
Promius Pharma LLC
$48
Sandoz Inc.
$44
Mayne Pharma Inc.
$41
PruGen, Inc. Pharmaceuticals
$37
Nabriva Therapeutics, plc
$35
Genentech USA, Inc.
$35
Mylan Institutional Inc.
$33
Blueprint Medicines Corporation
$24
Encore Dermatology Inc.
$21
Paratek Pharmaceuticals, Inc.
$18
Mylan Pharmaceuticals Inc.
$17
MAYNE PHARMA INC.
$16
Merck Sharp & Dohme Corporation
$16
Antares Pharma, Inc.
$11
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · AYVAKIT · Ameluz · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Cimzia · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · NUZYRA · OPZELURA · OTREXUP · Odomzo · Olux · Otezla · POTELIGEO · Poteligeo · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · Trianex · VALCHLOR · VTAMA · Winlevi · XELJANZ · XEPI · Xolair · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for dermatopathology physician in MI.
Geographic Context
Dermatopathology physicians within 10 mi
4
Per 100K population
0.6
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stawiski is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stawiski experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Stawiski performed 774 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stawiski receive payments from pharmaceutical companies?
Yes. Dr. Stawiski received a total of $22,892 from 44 companies across 1,198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stawiski's costs compare to other dermatopathology physicians in Grand Rapids?
Dr. Stawiski's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stawiski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Grand Rapids
Browse dermatopathology physicians in Grand Rapids ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in MI
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in MI
Which MI dermatopathology physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology